tirzepatide while ttc GLP-1s (Ozempic/Wegovy/Mounjaro/Zepbound, etc.) + TTC: when should you stop? Understanding GLP-1 Medications and Pregnancy

Wang YB, de Lartigue G, Page AJ

As scientific interest in obesity research, metabolic health, and endocrine physiology continues to expand, Retatrutide remains at the forefront of next-generation peptide research

In the SURMOUNT-5 trial, participants treated with Zepbound achieved an average weight reduction of 20.2% compared to 13.7% with Wegovy at 72 weeks

The pulsatile pattern is important because GH receptor sensitivity, downstream IGF-1 production, and metabolic effects all depend on the pulse amplitude and inter-pulse interval

- ,

Athletes are advised to never use a product that is marketed for research only. Side effects BPC-157 side effects (if any) are usually mild, especially when used at the proper dosage